guys, just to clarify, in the Just Stocks interview and in-line with the recent poster presentation and also the recent bile duct expansion announcement, we had a CR and an SD for cholangio. There is no PR for cholangio, but there is a PR on MAST (although i'm not sure what indication that is for). The recent bile duct expansion also mentions a cholangio patient in cohort 5, bringing the total number of cholangio patients we know about to 3, ahead of the actual bile duct expansion cohort.
Also the CR was cohort 2 at 1x10^7 and the SD was cohort 3 at 3x10^7. CR was IT and SD was IV.
check the below at 2.12m mark:
guys, just to clarify, in the Just Stocks interview and in-line...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
-0.005(6.10%) |
Mkt cap ! $563.6M | |||
| Open | High | Low | Value | Volume |
| 8.2¢ | 8.3¢ | 7.6¢ | $1.931M | 24.42M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 1392733 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 140950 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.7¢ |
Change
-0.005 ( 6.71 %) |
||||
| Open | High | Low | Volume | ||
| 8.2¢ | 8.3¢ | 7.6¢ | 9515046 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| IMU (ASX) Chart |